Paging Dr. Robot: Marvin Slepian on AI in health care Nov. 2, 2023 In a study led by University of Arizona Health Sciences researchers, about half of the participants said they would rather have a human – not artificial intelligence – oversee their diagnosis and treatment. Read more Image
Study seeks to transform methadone treatment for opioid use disorder Nov. 2, 2023 The MPACT study will develop and test a medical intervention to address critical gaps in current methadone maintenance treatment for opioid use disorder. Read more Image
Environmental justice center opens in Tucson Nov. 1, 2023 A $10 million Environmental Protection Agency grant is funding the Western Environmental Science Technical Assistance Center for Environmental Justice, or the WEST EJ Center. KOLD-TV (Tucson, AZ)
Project AzCANN: An honest cannabis education on campus and beyond Nov. 1, 2023 Arizona Cannabis Education, or AzCANN, is a project funded by a $1 million grant from the Arizona Department of Health Services that the Comprehensive Pain and Addiction Center at UArizona Health Sciences is using to develop educational materials on the responsible use and potential risks of cannabis. The Daily Wildcat
Health Sciences newsletter changes for the Veterans Day holiday Nov. 1, 2023 University of Arizona Health Sciences Read more
Health Sciences staff and faculty holiday appreciation day Nov. 1, 2023 University of Arizona BookStores Read more
$13M NIH grant funds research aimed at revitalizing immune systems of older adults Nov. 1, 2023 A $13 million NIH grant will help researchers learn more about how to rejuvenate the immune system by researching how T cells are created and maintained. Read more Image
Chronic morphine use for cancer pain may increase bone loss Oct. 31, 2023 Morphine is commonly used to treat bone pain associated with metastatic cancer, but research recently published in PAIN uncovered a mechanism by which chronic morphine use may increase bone loss and pain. Knowridge
Management of critically ill patients receiving medications for opioid use disorder Oct. 30, 2023 A review study by Brian L. Erstad, PharmD, MCCM, FCCP, FASHP, BCPS, professor and head of the Department of Pharmacy Practice and Science in the R. Ken Coit College of Pharmacy, and Melody J. Glenn, MD, professor in the Department of Emergency Medicine in the College of Medicine – Tucson, found that there are no published clinical practice guidelines or consensus statements to guide decision making in patients admitted to the ICU who were receiving medications for opioid use disorder prior to admission. Physician's Weekly
First-in-class regenerative therapeutic for Alzheimer's promising Oct. 30, 2023 Allopregnanolone, a regenerative therapeutic, has the potential to delay neurodegeneration in early Alzheimer's disease by promoting endogenous systems of renewal and repair, early clinical data show. Medscape